Literature DB >> 12210418

Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens.

Mara Cirone1, Laura Cuomo, Claudia Zompetta, Stefano Ruggieri, Luigi Frati, Alberto Faggioni, Giuseppe Ragona.   

Abstract

Several reports have suggested an association of human herpesvirus 6 (HHV-6) with multiple sclerosis. Autoreactive T lymphocytes directed against myelin components seem to contribute to the pathogenesis of the disease. It has been suggested that molecular mimicry between viral and self-antigens might be one of the mechanisms that determine the onset of several autoimmune diseases. Following this hypothesis, the purpose of the present study was to evaluate if HHV-6 could play a role in activating T cells capable of cross-reaction with an important myelin component, the myelin basic protein. T cell lines were established from 22 multiple sclerosis patients and from 16 healthy controls, and their capability to react to both virus and myelin basic protein antigens was compared. The analysis of T cell cross-reactivity in patients and controls did not show significant differences in the HHV-6 ability to activate myelin basic protein-reactive T cells. Similarly, the evaluation of the humoral immune response to HHV-6 in patients and controls did not mirror any abnormality in the HHV-6 status in multiple sclerosis patients. Therefore, although the findings of activity in vitro of T cell lines with dual specificity are consistent with the hypothesis of molecular mimicry, the lack of differences in cross-reactivity between patients and controls do not support molecular mimicry as an important mechanism in the physiopathology of this disease. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210418      PMCID: PMC7167112          DOI: 10.1002/jmv.10190

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  More mayhem from molecular mimics.

Authors:  L Steinman; M B Oldstone
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

2.  HHV-6 and multiple sclerosis.

Authors:  A R Coates; J Bell
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  HHV-6 and multiple sclerosis.

Authors:  A M Fillet; P Lozeron; H Agut; O Lyon-Caen; R Liblau
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

4.  Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease.

Authors:  K K Knox; J H Brewer; J M Henry; D J Harrington; D R Carrigan
Journal:  Clin Infect Dis       Date:  2000-10-20       Impact factor: 9.079

5.  Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

Authors:  S S Soldan; R Berti; N Salem; P Secchiero; L Flamand; P A Calabresi; M B Brennan; H W Maloni; H F McFarland; H C Lin; M Patnaik; S Jacobson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

6.  Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report.

Authors:  D V Ablashi; W Lapps; M Kaplan; J E Whitman; J R Richert; G R Pearson
Journal:  Mult Scler       Date:  1998-12       Impact factor: 6.312

7.  A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis.

Authors:  A M Gautam; R Liblau; G Chelvanayagam; L Steinman; T Boston
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

8.  Human herpesvirus-6 DNA in the saliva of paediatric oncology patients and controls.

Authors:  E G Lyall; H A Cubie
Journal:  J Med Virol       Date:  1995-12       Impact factor: 2.327

9.  Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis.

Authors:  P J Talbot; J S Paquette; C Ciurli; J P Antel; F Ouellet
Journal:  Ann Neurol       Date:  1996-02       Impact factor: 10.422

10.  Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.

Authors:  K W Wucherpfennig; J L Strominger
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

View more
  21 in total

Review 1.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

2.  Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient.

Authors:  Roger E Kelley; Joseph R Berger; Mary Espey; Brian P Kelley
Journal:  J Neurovirol       Date:  2014-11-04       Impact factor: 2.643

3.  Variant-specific tropism of human herpesvirus 6 in human astrocytes.

Authors:  Donatella Donati; Elena Martinelli; Riccardo Cassiani-Ingoni; Jenny Ahlqvist; Jean Hou; Eugene O Major; Steve Jacobson
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Herpesvirus infections of the central nervous system in immunocompromised patients.

Authors:  Uta Meyding-Lamadé; Cornelia Strank
Journal:  Ther Adv Neurol Disord       Date:  2012-09       Impact factor: 6.570

Review 6.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

Review 7.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

Review 8.  Role of pathogens in multiple sclerosis.

Authors:  Jane E Libbey; Matthew F Cusick; Robert S Fujinami
Journal:  Int Rev Immunol       Date:  2013-11-22       Impact factor: 5.311

9.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.